Aspen Aerogels (ASPN) Revenue (2016 - 2025)
Aspen Aerogels (ASPN) has disclosed Revenue for 13 consecutive years, with $73.0 million as the latest value for Q3 2025.
- For the quarter ending Q3 2025, Revenue fell 37.77% year-over-year to $73.0 million, compared with a TTM value of $352.9 million through Sep 2025, down 14.74%, and an annual FY2024 reading of $452.7 million, up 89.64% over the prior year.
- Revenue was $73.0 million for Q3 2025 at Aspen Aerogels, down from $78.0 million in the prior quarter.
- Across five years, Revenue topped out at $123.1 million in Q4 2024 and bottomed at $28.1 million in Q1 2021.
- Average Revenue over 5 years is $64.4 million, with a median of $59.6 million recorded in 2022.
- The sharpest move saw Revenue skyrocketed 144.55% in 2024, then plummeted 37.77% in 2025.
- Year by year, Revenue stood at $31.5 million in 2021, then surged by 89.39% to $59.6 million in 2022, then surged by 41.28% to $84.2 million in 2023, then skyrocketed by 46.15% to $123.1 million in 2024, then plummeted by 40.68% to $73.0 million in 2025.
- Business Quant data shows Revenue for ASPN at $73.0 million in Q3 2025, $78.0 million in Q2 2025, and $78.7 million in Q1 2025.